Top Markets
#1 Pleasing Gold Pleasing Gold +1,546.27%
#2 PulseChain PulseChain +55.72%
#3 Ontology Gas Ontology Gas +36.94%
#4 DogBull DogBull +36.89%
#5 BOOK OF MEME BOOK OF MEME +30.55%
#6 Neiro Neiro +21.85%
#7 Collect on Fanable Collect on Fanable +21.43%
#8 Nockchain Nockchain +19.56%
#9 Pump.fun Pump.fun +19.14%
#10 Unit Pump Unit Pump +19.14%
Coin of the day
Pleasing Gold Pleasing Gold
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
शेयरों में रैंक #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
शेयर मूल्य
$0.12164306
अंतिम समन्वयन: 2024-11-11
मार्केट कैप
$38.53M
बदलाव (1 दिन)
-4.14%
बदलाव (1 वर्ष)
0.00%
देश
AU
व्यापार PharmAust Limited (PAA)

श्रेणी

Healthcare
PharmAust Limited (PAA) के लिए P/S अनुपात
August 2026 को P/S अनुपात TTM: 0.00
PharmAust Limited की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी का वर्तमान P/S अनुपात (TTM) 0.00 है। 2024 के अंत में, कंपनी का P/S अनुपात 0.00 था।
PharmAust Limited के लिए 2001 से 2026 तक P/S अनुपात का इतिहास
हर वर्ष के अंत में P/S अनुपात
वर्ष P/S अनुपात परिवर्तन
2026 (TTM) 0.00 0.00%
2025 0.00 0.00%
2024 0.00 -100.00%
2023 8.53 29.96%
2022 6.56 -51.13%
2021 13.42 -6.50%
2020 14.36 611.37%
2019 2.02 20.63%
2018 1.67 -19.73%
2017 2.08 -15.55%
2016 2.47 -36.92%
2015 3.91 -40.73%
2014 6.60 108.20%
2013 3.17 87.09%
2012 1.70 -67.92%
2011 5.28 -58.41%
2010 12.70 360.27%
2009 2.76 66.79%
2008 1.65 66.92%
2007 0.99 -42.02%
2006 1.71 -41.66%
2005 2.93 -80.04%
2004 14.68 -38.19%
2003 23.75 159.55%
2002 9.15 0.00%
2001 0.00 0.00%
समान कंपनियों या प्रतिस्पर्धियों के लिए P/S अनुपात
कंपनी P/S अनुपात P/S अनुपात में अंतर देश
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH